| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/05/2008 | US20080132445 increasing milk production; inhibiting tumors; administering Galanin with prolactin; transgenic mammal |
| 06/05/2008 | US20080131976 Novel G protein coupled receptor protein, DNA its ligand |
| 06/05/2008 | US20080131964 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 06/05/2008 | US20080131963 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 06/05/2008 | US20080131933 Process of Producing a Plastid-Targeted Protein in Plant Cells |
| 06/05/2008 | US20080131932 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 06/05/2008 | US20080131931 Expression vector comprising nucleotide sequences coding protein which binds interleukin-10 related t cell-derived inducible factor (IL-TIF); for use in targeting cell for surgical removal |
| 06/05/2008 | US20080131930 Means and methods for regulating gene expression |
| 06/05/2008 | US20080131913 Canine 5-Hydroxytryptamine 2A and 2B Receptor Materials and Their Use |
| 06/05/2008 | US20080131910 Transcription factor specific immunoglobulin for use in treatment and prevention of cell proliferative, respiratory, kidney and liver disorders |
| 06/05/2008 | US20080131900 Variants of alpha-fetoprotein coding and expression sequences |
| 06/05/2008 | US20080131889 Novel human genes and gene expression products: II |
| 06/05/2008 | US20080131884 Tubulin Mutation Diagnostic |
| 06/05/2008 | US20080131871 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 06/05/2008 | US20080131500 methods of inactivating a protein, such as cleaving a disulfide bond of a protein, that involve contacting the protein with a reducing agent, a denaturant, and a hydroxide ion, wherein the pH of the composition is about 10.0 to about 14.0. Also disclosed are methods of treating or preventing a disease |
| 06/05/2008 | US20080131465 Group a Streptococcus Crge Protein |
| 06/05/2008 | US20080131452 Using primate hepadnavirus loop region polypeptide sequences as tool in developing vaccine to prevent and treat viral infection |
| 06/05/2008 | US20080131449 Mimetic oligopeptide for use in prevntion and treatment of viral infection of pigs; veterinary medicine |
| 06/05/2008 | US20080131448 Using interleukin receptor as tool in treatment cell proliferative disorders; antitumor agents |
| 06/05/2008 | US20080131447 Using alkyl hydroperoxide reductase as tool in developing vaccines to prevent and treat microorganismal infection; immunotherapy |
| 06/05/2008 | US20080131438 Antibodies to non-functional p2x7 receptor |
| 06/05/2008 | US20080131437 Using allelic variation in cell adhesion molecule (CD164) as tool in treatment and prevntion of skin, arthritic and gastrointestinal disorders |
| 06/05/2008 | US20080131430 Therapeutic Administration Of The Scrambled Anti-Angiogenic Peptide C16Y |
| 06/05/2008 | US20080131426 Using kallikren specific immunoglobulin as therapeutic tool in treating cardiocascular disorders; tissue repair |
| 06/05/2008 | US20080131421 Neisserial antigens |
| 06/05/2008 | US20080131417 Microarray-based analysis of rheumatoid arthritis markers |
| 06/05/2008 | US20080131411 Using vector transformation comprising wildtype fkhsf gene as therapeutic in prevention and treatment of skin and kidney disorders |
| 06/05/2008 | US20080131404 Hepatocytes |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | US20080127650 Molecular Motor |
| 06/05/2008 | DE10107186B4 Neue Form des PHGPx-Proteins als diagnostischer Marker bei männlicher Infertilität A new form of PHGPx protein as a diagnostic marker for male infertility |
| 06/05/2008 | CA2670965A1 Influenza vaccine formulation |
| 06/05/2008 | CA2670790A1 Polypeptides comprising fas activation and nkg2d-ligand domains |
| 06/05/2008 | CA2670532A1 Metastasis-specific peptides and their diagnostic and therapeutic applications |
| 06/05/2008 | CA2670471A1 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
| 06/05/2008 | CA2670460A1 Tslp vaccine for the treatment of th2 mediated inflammatory conditions |
| 06/05/2008 | CA2670107A1 Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer |
| 06/05/2008 | CA2668932A1 Modified soluble fgf receptor fc fusions with improved biological activity |
| 06/05/2008 | CA2666549A1 Il-17a/f heterodimeric polypeptides and therapeutic uses thereof |
| 06/05/2008 | CA2657811A1 Cell-free synthesis of proteins containing unnatural amino acids |
| 06/04/2008 | EP1927858A1 Conformationally constrained peptides that bind the ORL-1 receptor |
| 06/04/2008 | EP1927665A2 Methods and kits for diagnosing and treating b-Cell chronic lymphocytic leukemia (B-CLL) |
| 06/04/2008 | EP1927661A2 Anti-listeria bacteriocin |
| 06/04/2008 | EP1927660A2 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions |
| 06/04/2008 | EP1927659A1 Wisp polypeptides and therapeutical applications thereof |
| 06/04/2008 | EP1927657A2 Compositions and methods for producing antigen-presenting cells |
| 06/04/2008 | EP1927600A1 Homogeneous preparations of IL-28 and IL-29 |
| 06/04/2008 | EP1927598A1 Vaccine |
| 06/04/2008 | EP1927597A1 Antibacterial peptides |
| 06/04/2008 | EP1926819A1 Plant viral particles comprising a plurality of fusion proteins consisting of a plant viral coat protein, a peptide linker and a recombinant protein and use of such plant viral particles for protein purification |
| 06/04/2008 | EP1926811A1 Protein a production and purification without using animal derived components |
| 06/04/2008 | EP1926749A1 Cleavage of precursors of insulins by a variant of trypsin |
| 06/04/2008 | EP1926748A1 Glp-1 ( glucagon-like peptide-1 ) fusion polypeptides with increased peptidase resistance |
| 06/04/2008 | EP1926747A1 Mcp1 fusions |
| 06/04/2008 | EP1926746A1 Method for the production of biologically active rhngf |
| 06/04/2008 | EP1926745A1 Gene encoding cell wall mannoprotein and use thereof |
| 06/04/2008 | EP1926744A2 Clostridial toxin activatable clostridial toxins |
| 06/04/2008 | EP1926389A1 Low ph aerated products |
| 06/04/2008 | EP1794189B1 Ace-inhibitory whey hydrolysates |
| 06/04/2008 | EP1592703B1 Method for protein isolation in anoxic conditions |
| 06/04/2008 | EP1580267B1 Gene improving temperature-tolerance of acetic acid bacterium, acetic acid bacterium bred using the gene and process for producing vinegar using the acetic acid bacterium |
| 06/04/2008 | EP1546187B1 Purification process comprising microfiltration at elevated temperatures |
| 06/04/2008 | EP1463754B1 Cystine-knot fold protein |
| 06/04/2008 | EP1453553B1 Method and kit providing bioadhesive binding or coating with polyphenolic mussel proteins |
| 06/04/2008 | EP1354951B1 Method of examining ability to control nerve cell plasticity |
| 06/04/2008 | EP1192182B1 Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use |
| 06/04/2008 | EP1185658B1 Novel compounds from moraxella catarrhalis |
| 06/04/2008 | EP1151304B9 METHOD OF IDENTIFYING N-TERMINAL proBNP |
| 06/04/2008 | EP1137436B1 Stimulation of T-cells against self antigens using CTLA-4 blocking agents |
| 06/04/2008 | EP1019082B2 Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 06/04/2008 | EP1005534B1 Method for increasing the efficiency of recombinant aav production |
| 06/04/2008 | EP0990703B1 Novel polypeptide, dna encoding the same and use thereof |
| 06/04/2008 | EP0958305B1 Inhibitions of the interaction between p53 and mdm2 |
| 06/04/2008 | EP0946199B1 TGF beta 1-RESPONSIVE CELLS FROM BONE MARROW |
| 06/04/2008 | EP0920505B1 Mammalian cell surface antigens; related reagents |
| 06/04/2008 | EP0815438B1 Characterization of individual polymer molecules based on monomer-interface interactions |
| 06/04/2008 | EP0672143B1 Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/04/2008 | CN101194017A Conjugate comprising p21 protein for the treatment of cancer |
| 06/04/2008 | CN101193915A Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 06/04/2008 | CN101193913A Adiponectin variants |
| 06/04/2008 | CN101193912A Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof |
| 06/04/2008 | CN101193911A Novel cysteine-depleted hydrophobin fusion proteins, their production and use thereof |
| 06/04/2008 | CN101193910A HGF beta chain variants |
| 06/04/2008 | CN101193658A Pegylated G-CSF polypeptides and methods of producing same |
| 06/04/2008 | CN101193655A Vaccine against pandemic strains of influenza viruses |
| 06/04/2008 | CN101193653A Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies |
| 06/04/2008 | CN101191130A ChIFNGR1 gene and its coding protein and application |
| 06/04/2008 | CN101191129A Gene engineering domestic silkworm antibiotic peptide and its preparation method and application |
| 06/04/2008 | CN101190945A Preparation for specificity anticoagulant substance and application thereof |
| 06/04/2008 | CN101190944A Human cytokine and use thereof |
| 06/04/2008 | CN101190943A Jiangzhe snake venom double-chain peptide, preparation method and application thereof |
| 06/04/2008 | CN100392085C Vaccines |
| 06/04/2008 | CN100392083C DNA encoding ovine adenovirus (OAV 287) and its use as a viral vector |
| 06/04/2008 | CN100392082C Conserved neisserial antigens |
| 06/04/2008 | CN100392080C Variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use |
| 06/04/2008 | CN100392077C Carbohydrate oxidase and use thereof in baking |
| 06/04/2008 | CN100391979C Mono methoxy polyethylene glycol-insulin complex substance and its preparation method |
| 06/04/2008 | CN100391977C Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 06/04/2008 | CN100391974C Recombined collagen and synthesizing and expressing purifying process thereof |
| 06/04/2008 | CN100391973C Isolated dendritic cell membrane protein genes |